A longitudinal study of serum lipoproteins in relation to endogenous reproductive hormones during the menstrual cycle: Findings from the BioCycle study

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 9, 2010, Pages

  Mumford, Sunni L ^a,b   Schisterman, Enrique F ^a   Siega Riz, Anna Maria ^b   Browne, Richard W ^d   Gaskins, Audrey J ^a   Trevisan, Maurizio ^d,e   Steiner, Anne Z ^c   Daniels, Julie L ^b   Zhang, Cuilin ^a   Perkins, Neil J ^a   Wactawski Wende, Jean ^d  

^a Eunice Kennedy Shriver National Institutes of Child Health and Human Development   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; SEX HORMONE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; FEMALE; FOLLICULAR PHASE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; OUTCOME ASSESSMENT; OVULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; BLOOD; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GONADAL STEROID HORMONES; HUMANS; LIPOPROTEINS; LONGITUDINAL STUDIES; MENSTRUAL CYCLE; TRIGLYCERIDES; YOUNG ADULT;

EID: 77956606535     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0109     Document Type: Article

References (20)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280:605-613
3. Krauss RM, Burkman Jr RT 1992 The metabolic impact of oral contraceptives. Am J Obstet Gynecol 167:1177-1184
4. Knopp RH, Paramsothy P, Retzlaff BM, Fish B, Walden C, Dowdy A, Tsunehara C, Aikawa K, Cheung MC 2006 Sex differences in lipoprotein metabolism and dietary response: basis in hormonal differences and implications for cardiovascular disease. Curr Cardiol Rep 8:452-459
5. Knopp RH, Zhu X 1997 Multiple beneficial effects of estrogen on lipoprotein metabolism. J Clin Endocrinol Metab 82:3952-3954
6. Campos H, Walsh BW, Judge H, Sacks FM 1997 Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 82:3955-3963
7. Wactawski-Wende J, Schisterman EF, Hovey KM, Howards PP, Browne RW, Hediger M, Liu A, Trevisan M 2009 BioCycle study: design of the longitudinal study of the oxidative stress and hormone variation during the menstrual cycle. Paediatr Perinat Epidemiol 23:171-184
8. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
10. Robins JM, Hernán MA, Brumback B 2000 Marginal structural models and causal inference in epidemiology. Epidemiology 11:550-560
11. Lamon-Fava S, Fisher EC, Nelson ME, Evans WJ, Millar JS, Ordovas JM, Schaefer EJ 1989 Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size, and apolipoproteins. J Clin Endocrinol Metab 68:17-21
12. Cullinane EM, Yurgalevitch SM, Saritelli AL, Herbert PN, Thompson PD 1995 Variations in plasma volume affect total and low-density lipoprotein cholesterol concentrations during the menstrual cycle. Metabolism 44:965-971
13. Jones DY, Judd JT, Taylor PR, Campbell WS, Nair PP 1988 Menstrual cycle effect on plasma lipids. Metabolism 37:1-2
14. De Leon RG, Austin KL, Richards L, Guerrero F 1992 Lipid and hormonal profile of Panamanianwomenduring the menstrual cycle. Int J Gynecol Obstet 39:219-226
15. Kim HJ, Kalkhoff RK 1979 Changes in lipoprotein composition during the menstrual cycle. Metabolism 28:663-668
16. Larsen LF, Andersen HR, Hansen AB, Andersen O 1996 Variation in risk indicators of cardiovascular disease during the menstrual cycle: an investigation of within-subject variations in glutathione peroxidase, haemostatic variables, lipids and lipoproteins in healthy young women. Scand J Clin Lab Invest 56:241-249
17. Schijf CP, van der Mooren MJ, Doesburg WH, Thomas CM, Rolland R 1993 Differences in serum lipids, lipoproteins, sex hormone binding globulin and testosterone between the follicular and the luteal phase of the menstrual cycle. Acta Endocrinol (Copenhagen) 129:130-133
18. Srivastava RA, Baumann D, Schonfeld G 1993 In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse. Eur J Biochem 216:527-538
19. Zannis VI, Chroni A, Krieger M 2006 Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84:276-294
20. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M 1996 Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520